S. 2426: Equitable Community Access to Pharmacist Services Act

S.2426, the "Equitable Community Access to Pharmacist Services Act," would let Medicare treat pharmacists more like frontline clinicians — paying them for vaccinations, chronic‑disease checks and other services they’re already allowed to perform under state law. The move is aimed squarely at the primary‑care crunch in rural and underserved communities, where the drugstore often outlasts the local doctor’s office and becomes the only walk‑in health hub for miles.

Pharmacist groups argue the bill simply lets Medicare catch up to reality, where pharmacists already do medication management, point‑of‑care testing and chronic‑care counseling but can’t bill Part B for it. Long‑term care and senior‑care pharmacists have pressed lawmakers to recognize them as part of the primary‑care safety net, warning that without sustainable payment, independents in small towns will keep shuttering and older adults will lose one of the last accessible clinicians they see in person. They pitch S.2426 as a limited, targeted fix: Medicare could pay pharmacists only for services they’re allowed to do under state law and that would otherwise be covered when delivered by a physician.

Physician groups see a slippery slope. Organized medicine has spent years insisting that physician‑led care is the safest model, arguing that complex, older patients need teams anchored by doctors who can diagnose, manage multiple conditions and coordinate specialty referrals. Letting Medicare carve out a bigger billable role for pharmacists, they warn, risks normalizing a two‑tier system where urban seniors get integrated, physician‑led care while rural and low‑income patients are steered toward stand‑alone pharmacies for fragments of that same care.

S.2426 is less about scope of practice on paper — states already set that — and more about who gets paid to do what in communities that are losing clinicians fastest. If Medicare opens the door to pharmacist billing, it could stabilize rural pharmacies and expand access to vaccines, blood‑pressure checks and medication reviews. But it also raises hard questions about quality oversight, how pharmacists plug into existing care teams, and whether Washington is leaning on stopgaps instead of investing in long‑term fixes like training more primary‑care doctors, incentivizing rural practice and shoring up community health centers.